Cambridge, Massachusetts-(BUSINESSWIRE)-August 3, 2021- Moderna, Inc., a biotechnology company that is a pioneer in messenger RNA (mRNA) therapeutics and vaccines. (Nasdaq: mRNA) today announced that the...
Cambridge, Massachusetts-(BUSINESSWIRE)-February 2, 2021- VBIVaccines Inc. (Nasdaq: VBIV) (VBI), a commercial biopharmaceutical company developing next-generation infectious disease and immuno-oncology vaccines, today approved the submission of Biologics...
Singapore-(BUSINESSWIRE)-December 10, 2020- June 2020, Tichan A phase I clinical safety study in humans has begun to evaluate TY027, a monoclonal antibody (mAb) that specifically targets...
Taipei, Taiwan (AP) —In China, the number of people vaccinated with coronavirus vaccines is increasing rapidly, cities generally provide vaccines, and biotechnology companies provide free...
Cambridge, Massachusetts-(BUSINESSWIRE)-October 15, 2020- VBIVaccines Inc. (Nasdaq: VBIV) (VBI), a commercial biopharmaceutical company developing next-generation infectious disease and immuno-oncology vaccines, today has management team members VBI...
With Coronavirus The vaccine is still a few months away, but companies are rushing to try the next best thing. It is a drug that immediately...
Recent Comments